BOFA Buys 1.5L Gland Pharma Shares at ₹2826.6
BOFA Securities Europe SA bought 150,000 shares of Gland Pharma at ₹2826.6. Source: NSE Block Trades
Stock news timeline · GLAND
Gland Pharma
News timeline · Last 30 days
24 Aug 2026 – 22 Sep 2026 · Times in IST
- Timeline updates
- 16
- Bullish
- 3
- Neutral
- 12
- Bearish
- 1
- Active days
- 8
News timeline
Showing 16 of 16 updates · Newest first
No matching updates
Change the keyword or sentiment above, then click Apply.
Thursday, 17 Sep 20262 updates
North Rock SG Sells 1.5L Gland Pharma Shares at ₹2,826.6
North Rock SG VCC sold 150,000 shares of Gland Pharma at Rs 2826.6 each. Source: NSE Block Trades
Sunday, 13 Sep 20262 updates
Gland Pharma to Acquire US Unit for $501K
Gland Pharma to acquire 100% equity in Gland Pharma USA for $501,208. Move simplifies corporate structure, making Gland Pharma USA a direct wholly-owned subsidiary. Source: ScoutQuest
Gland Pharma Fined ₹70K by NSE, BSE for SEBI Breach
Gland Pharma paid ₹70,000 fines each to NSE & BSE for a technical breach of SEBI LODR regulations. Board advised strict adherence to compliance and strengthened internal processes to prevent future non-compliance. Source: BSE
Tuesday, 08 Sep 20262 updates
Gland Pharma Hosts Investor Meet on Sept 11
Gland Pharma to meet analysts and investors on Sept 11. Event may include corporate updates or Q&A sessions. Source: Livesquawk
Gland Pharma: Company Scheduled To Meet Analysts And Investors On September 11
Monday, 07 Sep 20261 update
Gland Pharma Rises 1.4%, Up 58.4% YoY
Gland Pharma gains for third session, up 1.4% at Rs 2974.6. Stock rose 58.4% YoY vs Nifty's 4.1% and Nifty Pharma's 21.5%. Source: Business Standard
Friday, 04 Sep 20265 updates
Gland Pharma to Host Analyst Meet with Kotak MF on Sep 9, 2026
Gland Pharma Ltd announces schedule for Analyst/Investor Meet on Sep 9, 2026 with Kotak Mutual Fund. Meeting details subject to change due to exigencies from Investor, Analyst, or Company. Source: BSE
Gland Pharma Sees 199x Surge in Trade Volume; Other Stocks Follow Suit
Gland Pharma saw 106.67L shares traded by 10:46 IST, a 199.3x surge over its 2-week average of 53,501 shares. Tata Tech, Nuvoco Vistas, Medplus Health, and HBL Engineering also saw volume spikes on BSE today. Source: Business Standard
Gland Pharma Falls on ₹2,100 Cr Block Deal; Fosun May Have Sold 5% Stake
Gland Pharma shares dropped after a ₹2,100 cr block deal involving 75 lakh shares (~4.5% equity). Fosun Pharma likely sold up to 5% stake; stock trades at ₹2,878.9, up 65% YTD. Source: CNBC TV 18
Gland Pharma's ₹2,178 Cr Block Trade at ₹2,904/Share
Gland Pharma executed a BSE block trade of ~7.5M shares at Rs 2,904 per share. The total value of the block trade was Rs 2,178 crore (pre-open). Source: Livesquawk
Gland Pharma: Fosun Pharma Likely To Sell 5% Equity In Co Via Block Deal. - NDTV Profit
Thursday, 03 Sep 20261 update
Fosun to Sell 5% Stake in Gland Pharma via Block Deal
Fosun Pharma plans to sell 5% equity in Gland Pharma via a block deal. Sources confirm the block deal initiation for Gland Pharma. Source: ScoutQuest
Tuesday, 01 Sep 20262 updates
Gland Pharma: USFDA Completes Inspection At VSEZ Sterile Oncology Facility With Zero Form 483 Observations.
Gland Pharma's Vizag Plant Clears USFDA Inspection with Zero Observations
Gland Pharma's Visakhapatnam facilities passed USFDA inspection with zero Form 483 observations. The inspection, conducted between Aug 24 and Sep 1, 2026, followed GMP standards. Source: BSE